KAYLA ADAMS: Open Payments
NPI 1366026965 · CHARLESTON, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 31 payments from 8 companies in 2025. Trend: 2023 $643 · 2024 $1,085 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $238 |
| Novartis Pharmaceuticals Corporation | 8 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| Kestra Medical Technology Services, Inc. | 4 | $70 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $26 |
| Amgen Inc. | 1 | $15 |
| Medtronic, Inc. | 1 | $14 |
Products named: Kerendia, LEQVIO, JARDIANCE, Assure WCD, WAINUA, LifeVest, REPATHA, AURORA EV-ICD MRI SURESCAN.
Industry payments across WV — which companies pay providers there.
